Novartis ESMO Event Presentation

PSA50 response was >2.5X more frequent with Pluvicto than with ARPI change among evaluable patients Waterfall plots of best percentage change from baseline in PSA 100 177 Lu-PSMA-617 (n = 213) ARPI change (n = 221) Best percentage change in PSA from baseline (%) 86220 40 -20 -40 -60 -80 -100 17 NOVARTIS ESMO EVENT | OCTOBER 24, 2023 | INVESTOR PRESENTATION Confirmed decrease ≥ 50%: 57.6% Confirmed decrease ≥ 50%: 20.4% NOVARTIS | Reimagining Medicine

View entire presentation